Hain Celestial Reports Fiscal First Quarter 2026 Financial Results

Hain Celestial Reports Fiscal First Quarter 2026 Financial Results GlobeNewswire November 07, 2025 HOBOKEN, N.J., Nov. 07, 2025 (GLOBE NEWSWIRE) — The Hain Celestial Group, Inc. (Nasdaq: HAIN), a leading global health and wellness company whose purpose is to inspire healthier living through better-for-you brands, today reported financial results for its fiscal first quarter ended […]

Seer and Collaborators Unveil Broad New Data Demonstrating the Translational Power of Deep Proteomics at HUPO 2025

Seer and Collaborators Unveil Broad New Data Demonstrating the Translational Power of Deep Proteomics at HUPO 2025 Studies spanning cardiovascular, aging, and cancer biology highlight how Seer's Proteograph(R) platform is enabling discovery at population scale GlobeNewswire November 07, 2025 REDWOOD CITY, Calif., Nov. 07, 2025 (GLOBE NEWSWIRE) — Seer, Inc. (Nasdaq: SEER), the pioneer and

Onex Reports Third Quarter 2025 Results

Onex Reports Third Quarter 2025 Results GlobeNewswire November 07, 2025 All amounts in U.S. dollars unless otherwise stated TORONTO, Nov. 07, 2025 (GLOBE NEWSWIRE) — Onex Corporation (TSX: ONEX) today announced its financial results for the third quarter ended September 30, 2025. “Onex' third quarter results reflect ongoing progress across the business,” said Bobby Le

Prime Medicine Reports Third Quarter 2025 Financial Results and Provides Business Updates

Prime Medicine Reports Third Quarter 2025 Financial Results and Provides Business Updates GlobeNewswire November 07, 2025 — New preclinical data for PM577 in Wilson's Disease (WD) to be presented at AASLD; on-track to file IND and/or CTA in H1'26, with initial clinical data expected in 2027 — — Nominated PM647 as development candidate for Alpha-1

Ocular Therapeutix(TM) Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Ocular Therapeutix(TM) Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire November 07, 2025 BEDFORD, Mass., Nov. 07, 2025 (GLOBE NEWSWIRE) — Ocular Therapeutix, Inc. (NASDAQ: OCUL, “Ocular”), an integrated biopharmaceutical company committed to redefining the retina experience, today announced that it has granted inducement awards to one newly hired non-executive employee. The award was

MADD Canada Unveils Roadside Memorial Sign in Trenton in Honour of Rebecca Beatty Killed in Impaired Driving Crash

MADD Canada Unveils Roadside Memorial Sign in Trenton in Honour of Rebecca Beatty Killed in Impaired Driving Crash GlobeNewswire November 07, 2025 OAKVILLE, Ontario, Nov. 07, 2025 (GLOBE NEWSWIRE) — A new MADD Canada roadside memorial sign will be unveiled today in Trenton in honour of 22-year-old Rebecca Beatty, who was tragically killed in an

Memo Therapeutics AG Presents Long Term Follow-Up Data from its Phase II SAFE KIDNEY Trial of Potravitug and Real World Data on the Challenges and Re-source Utilization of Managing Kidney Transplant Recipients at ASN Kidney Week Meeting

Memo Therapeutics AG Presents Long Term Follow-Up Data from its Phase II SAFE KIDNEY Trial of Potravitug and Real World Data on the Challenges and Re-source Utilization of Managing Kidney Transplant Recipients at ASN Kidney Week Meeting GlobeNewswire November 07, 2025 PRESS RELEASE Memo Therapeutics AG Presents Long Term Follow-Up Data from its Phase II

AMC Networks Inc. Reports Third Quarter 2025 Results

AMC Networks Inc. Reports Third Quarter 2025 Results GlobeNewswire November 07, 2025 NEW YORK, Nov. 07, 2025 (GLOBE NEWSWIRE) — AMC Networks Inc. (“AMC Networks” or the “Company”) (NASDAQ: AMCX) today reported financial results for the third quarter ended September 30, 2025. Chief Executive Officer Kristin Dolan said: “Our performance in the third quarter marks

Whitestone REIT Acquires Primely Located World Cup Plaza in Frisco, Texas

Whitestone REIT Acquires Primely Located World Cup Plaza in Frisco, Texas GlobeNewswire November 07, 2025 Center located adjacent to the 21,000-seat Toyota Stadium that attracts more than 1.4 million visitors annually and will serve as a base camp for the 2026 FIFA World Cup Property strategically situated at the busiest intersection north of 121 and

Complete Tumor Regressions Observed in Preclinical Models with Co-administration of Cyncado’s A2B and A2A Receptor Antagonists and Cancer Vaccines

Complete Tumor Regressions Observed in Preclinical Models with Co-administration of Cyncado's A2B and A2A Receptor Antagonists and Cancer Vaccines Data from studies conducted by investigators at the National Cancer Institute at NCI laboratories, part of a multi-year research effort, will be presented at SITC GlobeNewswire November 07, 2025 Dover, DE, Nov. 07, 2025 (GLOBE NEWSWIRE)

Scroll to Top